Dissemination of clinical isolates of Klebsiella oxytoca harboring CMY-31, VIM-1, and a new OXY-2-type variant in the community

Antimicrobial Agents and Chemotherapy

Volumn 55, Issue 7, 2011, Pages 3164-3168

  Tsakris, Athanassios ^a   Poulou, Aggeliki ^b   Markou, Fani ^b   Pitiriga, Vassiliki ^a   Piperaki, Evangelia Theophano ^a   Kristo, Ioulia ^c   Pournaras, Spyros ^c  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b General District Hospital of Serres   (Greece)

^c UNIVERSITY OF THESSALY   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AZTREONAM; BETA LACTAMASE AMPC; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN; CIPROFLOXACIN; CMY 31 AMPC CEPHALOSPORINASE; GENTAMICIN; IMIPENEM; MEROPENEM; METALLO BETA LACTAMASE; OXY 2 BETA LACTAMASE TYPE VARIANT; PIPERACILLIN PLUS TAZOBACTAM; TIGECYCLINE; TRIMETHOPRIM; UNCLASSIFIED DRUG; VIM 1 METALLO BETA LACTAMASE;

ADULT; AGAR DILUTION; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CLINICAL ARTICLE; CLONE; ENTEROBACTERIAL REPETITIVE INTERGENIC CONSENSUS POLYMERASE CHAIN REACTION; ENVIRONMENTAL EXPOSURE; FEMALE; GENE; GENE MAPPING; HEALTH CARE FACILITY; HUMAN; INTEGRON; KLEBSIELLA OXYTOCA; MALE; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR TYPING; MULTIDRUG RESISTANCE; NUCLEOTIDE SEQUENCE; OUTPATIENT; PHENOTYPIC CARBAPENEMASE TEST; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PULSED FIELD GEL ELECTROPHORESIS; URINARY TRACT INFECTION;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; FEMALE; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA OXYTOCA; MALE; MICROBIAL SENSITIVITY TESTS; MUTATION; PLASMIDS; POLYMERASE CHAIN REACTION; PROMOTER REGIONS, GENETIC;

EID: 79959261031     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00102-11     Document Type: Article

References (32)

1. Adler, H., et al. 2008. Plasmid-mediated AmpC β-lactamases in Enterobacteriaceae lacking inducible chromosomal AmpC genes: prevalence at a Swiss university hospital and occurrence of the different molecular types in Switzerland. J. Antimicrob. Chemother. 61:457-458.
2. Carattoli, A., et al. 2010. Complete nucleotide sequence of the IncN plasmid pKOX105 encoding VIM-1, QnrS1 and SHV-12 proteins in Enterobacteriaceae from Bolzano, Italy compared with IncN plasmids encoding KPC enzymes in the U. S. A. J. Antimicrob. Chemother. 65:2070-2075.
3. Chen, J. Y., P. S. Chen, Y. P. Chen, W. T. Lee, and L. J. Lin. 2006. Community-acquired Klebsiella oxytoca endocarditis: a case report. J. Infect. 52: 129-131.
4. Clinical and Laboratory Standards Institute. 2008. Performance standards for antimicrobial susceptibility testing; 18th informational supplement. CLSI M100-S18. Clinical and Laboratory Standards Institute, Wayne, PA.
5. IMP-8, associated with OXY hyperproduction, in the intensive care unit of a community hospital in Spain. J. Antimicrob. Chemother. 65:1071-1073.
6. Doi, Y., et al. 2009. Reduced susceptibility to cefepime among Escherichia coli clinical isolates producing novel variants of CMY-2 β-lactamase. Antimicrob. Agents Chemother. 53:3159-3161.
7. Fevre, C., et al. 2005. Six groups of the OXY β-lactamase evolved over millions of years in Klebsiella oxytoca. Antimicrob. Agents Chemother. 49: 3453-3462. (Pubitemid 41060595)
8. Fournier, B., A. Gravel, D. C. Hooper, and P. Roy. 1999. Strength and regulation of the different promoters for chromosomal β-lactamase of Klebsiella oxytoca. Antimicrob. Agents Chemother. 43:850-855. (Pubitemid 29165748)
9. Fournier, B., P. H. Lagrange, and A. Philippon. 1996. β-Lactamase gene promoters of 71 clinical strains of Klebsiella oxytoca. Antimicrob. Agents Chemother. 40:460-463.
10. Galani, I., M. Souli, Z. Chryssouli, K. Orlandou, and H. Giamarellou. 2005. Characterization of a new integron containing bla(VIM-1) and aac(6′)-IIc in an Enterobacter cloacae clinical isolate from Greece. J. Antimicrob. Chemother. 55:634-638.
11. Gazouli, M., L. S. Tzouvelekis, A. C. Vatopoulos, and E. Tzelepi. 1998. Transferable class C β-lactamases in Escherichia coli strains isolated in Greek hospitals and characterization of two enzyme variants (LAT-3 and LAT-4) closely related to Citrobacter freundii AmpC β-lactamase. J. Antimicrob. Chemother. 42:419-425. (Pubitemid 28473000)
12. Gheorghiu, R., M. Yuan, L. M. Hall, and D. M. Livermore. 1997. Bases of variation in resistance to β-lactams in Klebsiella oxytoca isolates hyperproducing K1 β-lactamase. J. Antimicrob. Chemother. 40:533-541.
13. Lévesque, C., L. Piché, C. Larose, and P. H. Roy. 1995. PCR mapping of integrons reveals several novel combinations of resistance genes. Antimicrob. Agents Chemother. 39:185-191.
14. Mammeri, H., L. Poirel, and P. Nordmann. 2003. In vivo selection of a chromosomally encoded β-lactamase variant conferring ceftazidime resistance in Klebsiella oxytoca. Antimicrob. Agents Chemother. 47:3739-3742. (Pubitemid 37484981)
15. Miriagou, V., E. Tzelepi, D. Gianneli, and L. S. Tzouvelekis. 2003. Escherichia coli with a self-transferable, multiresistant plasmid coding for metallo-β-lactamase VIM-1. Antimicrob. Agents Chemother. 47:395-397.
16. VIM-1-carrying integron In-e541. Int. J. Antimicrob. Agents 32:540-541.
17. Pérez-Pérez, F. J., and N. D. Hanson. 2002. Detection of plasmid-mediated AmpC β-lactamase genes in clinical isolates by using multiplex PCR. J. Clin. Microbiol. 40:2153-2162.
18. Poirel, L., C. Héritier, V. Tolün, and P. Nordmann. 2004. Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae. Antimicrob. Agents Chemother. 48:15-22.
19. Poulou, A., et al. 2010. Recurrent healthcare-associated community-onset infections due to Klebsiella pneumoniae producing VIM-1 metallo-β- lactamase. J. Antimicrob. Chemother. 65:2538-2542.
20. Romero, E. D., et al. 2007. Prevalence of clinical isolates of Escherichia coli and Klebsiella spp. producing multiple extended-spectrum β-lactamases. Diagn. Microbiol. Infect. Dis. 59:433-437.
21. Sturm, P. D., et al. 2010. Prevalence, molecular characterization, and phenotypic confirmation of extended-spectrum β-lactamases in Escherichia coli, Klebsiella pneumoniae, and Klebsiella oxytoca at the Radboud University Nijmegen Medical Centre in The Netherlands. Microb. Drug Resist. 16:55-60.
22. Tenover, F. C., et al. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.
23. Tsakris, A., et al. 2007. Transmission in the community of clonal Proteus mirabilis carrying VIM-1 metallo-β-lactamase. J. Antimicrob. Chemother. 60:136-139.
24. Tsakris, A., et al. 2009. Large dissemination of VIM-2-metallo-β- lactamase-producing Pseudomonas aeruginosa strains causing health care-associated community-onset infections. J. Clin. Microbiol. 47:3524-3529.
25. Tsakris, A., et al. 2010. A simple phenotypic method for the differentiation of metallo-β-lactamases and class-A KPC carbapenemases in Enterobacteriaceae clinical isolates. J. Antimicrob. Chemother. 65:1664-1671.
26. Tsakris, A., et al. 2000. Outbreak of infections caused by Pseudomonas aeruginosa producing VIM-1 carbapenemase in Greece. J. Clin. Microbiol. 38:1290-1292.
27. Tzelepi, E., et al. 2003. Extended-spectrum β-lactamase types in Klebsiella pneumoniae and Escherichia coli in two Greek hospitals. Int. J. Antimicrob. Agents 21:285-288.
28. Watson, J. T., et al. 2005. Outbreak of catheter-associated Klebsiella oxytoca and Enterobacter cloacae bloodstream infections in an oncology chemotherapy center. Arch. Intern. Med. 165:2639-2643.
29. Yamasaki, K., et al. 2010. Laboratory surveillance for prospective plasmidmediated AmpC β-lactamases in the Kinki region of Japan. J. Clin. Microbiol. 48:3267-3273.
30. Yan, J. J., et al. 2001. Metallo-β-lactamases in clinical Pseudomonas isolates in Taiwan and identification of VIM-3, a novel variant of the VIM-2 enzyme. Antimicrob. Agents Chemother. 45:2224-2228.
31. Zárate, M. S., et al. 2008. Outbreak of OXY-2-producing Klebsiella oxytoca in a renal transplant unit. J. Clin. Microbiol. 46:2099-2101.
32. Zioga, A., et al. 2009. CMY-31 and CMY-36 cephalosporinases encoded by ColE1-like plasmids. Antimicrob. Agents Chemother. 53:1256-1259.